Cianci C - Search Results

1

Clinical benefit of bone-targeted radiometabolic therapy with 153Sm-EDTMP combined with chemotherapy in patients with metastatic hormone-refractory prostate cancer.

Ricci S, Boni G, Pastina I, Genovesi D, Cianci C, Chiacchio S, Orlandini C, Grosso M, Alsharif A, Chioni A, Di Donato S, Francesca F, Selli C, Rubello D, Mariani G. Ricci S, et al. Among authors: cianci c. Eur J Nucl Med Mol Imaging. 2007 Jul;34(7):1023-30. doi: 10.1007/s00259-006-0343-8. Epub 2007 Jan 23. Eur J Nucl Med Mol Imaging. 2007. PMID: 17242920

2

Safety and antitumor efficacy of (153)Sm-EDTMP and docetaxel administered sequentially to patients with metastatic castration-resistant prostate cancer.

Borsò E, Boni G, Pastina I, Lorenzoni A, Cianci C, Federici F, Mazzarri S, Orlandini C, Francesca F, Selli C, Ricci S, Rubello D, Mariani G. Borsò E, et al. Among authors: cianci c. Nucl Med Commun. 2014 Jan;35(1):88-94. doi: 10.1097/MNM.0000000000000023. Nucl Med Commun. 2014. PMID: 24157942

3

Cytochrome 450 1B1 (CYP1B1) polymorphisms associated with response to docetaxel in Castration-Resistant Prostate Cancer (CRPC) patients.

Pastina I, Giovannetti E, Chioni A, Sissung TM, Crea F, Orlandini C, Price DK, Cianci C, Figg WD, Ricci S, Danesi R. Pastina I, et al. Among authors: cianci c. BMC Cancer. 2010 Sep 27;10:511. doi: 10.1186/1471-2407-10-511. BMC Cancer. 2010. PMID: 20875115 Free PMC article.

4

Radium 223 dichloride: a multidisciplinary approach to metastatic castration-resistant prostate cancer.

Borsò E, Boni G, Galli L, Ricci S, Farnesi A, Mazzarri S, Cianci C, Mariani G, Falcone A. Borsò E, et al. Among authors: cianci c. Future Oncol. 2015;11(2):323-31. doi: 10.2217/fon.14.157. Epub 2014 Jul 30. Future Oncol. 2015. PMID: 25075962

5

²²³Ra-chloride therapy in men with hormone-refractory prostate cancer and skeletal metastases: Real-world experience.

Boni G, Mazzarri S, Cianci C, Galli L, Farnesi A, Borsatti E, Bortolus R, Fratino L, Gobitti C, Lamaj E, Ghedini P, Rizzini EL, Massari F, Dionisi V, Fanti S, Volterrani D, Monari F. Boni G, et al. Among authors: cianci c. Tumori. 2018 Mar-Apr;104(2):128-136. doi: 10.1177/0300891618765571. Epub 2018 Apr 18. Tumori. 2018. PMID: 29714668

6

Double 5-fluorouracil modulation with folinic acid and recombinant alpha-2B-interferon. A phase I-II study in metastatic colorectal cancer patients.

Brunetti I, Falcone A, Bertuccelli M, Cianci C, Ricci S, Conte PF. Brunetti I, et al. Among authors: cianci c. Am J Clin Oncol. 1994 Jun;17(3):210-4. doi: 10.1097/00000421-199406000-00005. Am J Clin Oncol. 1994. PMID: 8192103 Clinical Trial.

7

Oral doxifluridine in elderly patients with metastatic colorectal cancer: a multicenter phase II study.

Falcone A, Pfanner E, Ricci S, Bertuccelli M, Cianci C, Carrai M, De Marco S, Ceribelli A, Barduagni M, Calabresi F, et al. Falcone A, et al. Among authors: cianci c. Ann Oncol. 1994 Oct;5(8):760-2. doi: 10.1093/oxfordjournals.annonc.a058983. Ann Oncol. 1994. PMID: 7826910 Free article. Clinical Trial.

8

Alpha-2B-interferon plus floxuridine in metastatic renal cell carcinoma. A phase I-II study.

Falcone A, Cianci C, Ricci S, Brunetti I, Bertuccelli M, Conte PF. Falcone A, et al. Among authors: cianci c. Cancer. 1993 Jul 15;72(2):564-8. doi: 10.1002/1097-0142(19930715)72:2<564::aid-cncr2820720238>3.0.co;2-p. Cancer. 1993. PMID: 8319188 Clinical Trial.

9

Treatment of metastatic renal cell carcinoma with constant-rate floxuridine infusion plus recombinant alpha 2b-interferon.

Falcone A, Cianci C, Pfanner E, Ricci S, Lencioni M, Brunetti I, Giulianotti PC, Vannucci L, Mosca F, Conte PF. Falcone A, et al. Among authors: cianci c. Ann Oncol. 1996 Aug;7(6):601-5. doi: 10.1093/oxfordjournals.annonc.a010677. Ann Oncol. 1996. PMID: 8879374 Free article. Clinical Trial.

10

How radical prostatectomy procedures have changed over the last 10 years in Italy: a comparative analysis based on more than 1500 patients participating in the MIRROR-SIU/LUNA and the Pros-IT CNR study.

Gacci M, Artibani W, Bassi P, Bertoni F, Bracarda S, Briganti A, Carmignani G, Carmignani L, Conti G, Corvò R, De Nunzio C, Fusco F, Graziotti P, Greco I, Maggi S, Magrini SM, Mirone V, Montironi R, Morgia G, Muto G, Noale M, Pecoraro S, Porreca A, Ricardi U, Russi E, Russo G, Salonia A, Simonato A, Serni S, Tomasini D, Tubaro A, Zagonel V, Crepaldi G; MIRROR-SIU/LUNA Study Group and the Pros-IT CNR Study Group. Gacci M, et al. World J Urol. 2021 May;39(5):1445-1452. doi: 10.1007/s00345-020-03350-5. Epub 2020 Aug 1. World J Urol. 2021. PMID: 32740803

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

108 results

Search Page

Filters